ANZUP celebrates Margaret McJannett as she "retires" (yeah right I suspect there won't be much putting up of feet), and welcomes our new CEO Samantha Oakes

Many thanks to ESMO - Eur. Oncology for providing wonderful opportunity and platform to highlight our work. Had insightful conversations with oncologists around the world. We hope our work will improve survivorship care for all cancer patients #EsmoSarcomaandRareTumour24 #CancerSurvivor

irishexaminer.com/news/spotlight…

Survey based research conducted by our team in Tallaght University Hospital, describing the negative impact of testicular cancer on survivors. Unfortunately, not enough support systems are in place at present to cater their needs. #ServeTheSurvivors #CancerSurvivors

Key points from Ray McDermott on PSA recurrence. Note the first one - I’ve lost count of the number of times the solution to the unexpected progression (including known M1) was “the other doc told me I could stop the injections and I haven’t had one for 2 years.” #APCCC24

Second BCR (without correlate on NGI) after salvage radiation and/or after metastases directed therapy: How to manage these patients? Presented by Ray McDermott St Vincent's University Hospital (SVUH). #APCCC24 Written coverage by Zach Klaassen Georgia Cancer Center on UroToday > bit.ly/3QkiRWJ Advanced Prostate Cancer Consensus Conference

🙌A huge thank you to Hannah Smullen, TCD Horse Racing Soc and everyone who came together to raise over €7800 at the Cheltenham Preview Night in aid of Cancer Trials Ireland! 📸Luke O’Neill, Hannah Smullen, Eibhlin Mulroe 🌈 & Emma Osborne. Frances Crowley #CancerResearch

The FEED study, exploring the impact of a multimodal nutritional intervention in patients undergoing chemotherapy for #PancreaticCancer, is now open in St Vincent's University Hospital (SVUH). 👏 Congrats to PI's Ray McDermott, Oonagh and the team. Read more: bit.ly/4alHFEU #CancerResearch

We are so pleased for, and proud of our friend and colleague Siobhan Gaynor whose patient-led MBC study today informs not one but 2⃣ poster presentations ASCO 2024. Sending oceans of goodwill across the pond to you from 🇮🇪!! Seamus O’Reilly MD PhD Eibhlin Mulroe 🌈 Angela Clayton-Lea

Delighted to present the prognostic implications of PSA at 7mo in #mHSPC in this landmark analysis of #ENZAMET representing CancerTrialsIreland 🌈 and honoured to be a Conquer Cancer, the ASCO Foundation Merit award recipient Christopher Sweeney, MBBS Ian Davis Ray McDermott John McCaffrey St Vincent's University Hospital (SVUH) Mater Hospital Advanced Cancer Care

In the coming weeks, we will start the first Irish study to trial a personalised cancer vaccine for patients with early-stage non-small cell lung cancer. It's a groundbreaking development and one of the first of such trials worldwide. Front page of today's Irish Examiner

Interesting podcast on why trials are necessary in Ireland. Ray McDermott CancerTrialsIreland 🌈 Grainne O'Kane HSE Ireland Simon Harris TD #KRAS #Braf #HER2 podcasts.apple.com/ie/podcast/lea…

We applaud the appointment of Prof Grainne O’Kane as the Pat Smullen Chair in Pancreatic Cancer University College Dublin The position is part-funded (€900K over 5 years) through the Pat Smullen Pancreatic Cancer Fund, with matching funding from NCCP Read more: bit.ly/4fXyJta

It was clear to see the enormous impact of Pat Smullen's legacy at The Curragh Racecourse this Saturday. The funds raised by Pat's family, friends, and the horse racing community since 2019 have made new clinical trials and treatment options for patients with #PancreaticCancer possible.

Great to see these positive results. Europe🇪🇺and collaborating 🇨🇦🇧🇷countries answering questions in prostate cancer. Nice to see Irish patient participation Cork University Hospitals and Dublin🇮🇪 CancerTrialsIreland 🌈 Ray McDermott #ESMO24 Congratukations to PIs tombal and silke gillessen

⁦Ray McDermott⁩ 's ⁦CancerTrialsIreland 🌈⁩ 13-21 Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study - was a forerunner to PEACE 3 ⁦EORTC⁩ 1333 trial pubmed.ncbi.nlm.nih.gov/34512801/

A proud day. Thank you to everyone who donated and supported us. And especially to all my colleagues PUNCH Consulting you guys are amazing 💙 CancerTrialsIreland 🌈

We are very proud that the paper is online! Sincere thanks to our scientific committee and all panellists. Manuscript is open access, please use and distribute it! Hope to see you at the first edition of Advanced Prostate Cancer Consensus Conference Diagnostics Ken Herrmann prof. Stefano Fanti

Succinct informative overview of PEACE III results by Ray McDermott. An advance in optimising treatment for mCRPC.Another great example of how Irish hospitals can be involved in advancing cancer care at a global level. CancerTrialsIreland 🌈 Cork University Hospitals Cancer Trials Cork Paul Kelly

Absolutely amazing!